VF
CYTH

Virtu Financial’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Virtu Financial’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,732
Closed -$15K – 2109
2023
Q3 		$15K Buy
+10,732
New +$16.5K ﹤0.01% 1062
2022
Q1 		– Sell
-22,247
Closed -$83K – 2161
2021
Q4 		$83K Buy
+22,247
New +$126K 0.01% 1205

Other funds holding CYTH

FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial's CYTH Position: Q4 2023 in Review

Virtu Financial sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q4 2023, closing a stake of 10,732 shares — an estimated $15K sold.

Virtu Financial first reported a position in CYTH in Q4 2021 and held it in 2 quarters. The position peaked at $83K in Q4 2021. 23 funds tracked by Wall St. Rank hold CYTH as of Q4 2023.

  • Virtu Financial reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 10,732 Cyclo Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $15K.
  • Virtu Financial first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Virtu Financial's Cyclo Therapeutics, Inc. Common Stock position peaked at $83K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.